1. ACOG. Practice Bulletin. N. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct. Vol. 130. N. 4. P. e168–e186.
2. Ueda A., Nakakita B., Chigusa Y. et al. Impact of efforts to prevent maternal deaths due to obstetric hemorrhage on trends in epidemiology and management of severe postpartum hemorrhage in Japan: a nationwide retrospective study. BMC Pregnancy Childbirth. 2022 Jun 17. Vol. 22. N. 1. 496 p. DOI: 10.1186/s12884-022-04824-7. PMID: 35715763; PMCID: PMC9205073.
3. Say L., Chou D., Gemmill A. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014. Vol. 2. P. e323–33.
4. Fan D., Xia Q., Liu L., et al. The incidence of postpartum hemorrhage in pregnant women with placenta previa: a systematic review and meta-analysis. PLoS One 2017. Vol. 12.
5. Jauniaux E., Alfirevic Z., Bhide A.G. et al. Placenta praevia and placenta accreta: diagnosis and management // BJOG. Int. J. Gynaecol. Obstet. 2019. Vol. 126. N. 1. P. e1–e48.
6. De Mucio B., Serruya S., Alemán A. et al. A systematic review and meta‐analysis of cesarean delivery and other uterine surgery as risk factors for placenta accrete. Int. J. Gynecol. Obstet. 2019. Vol. 147. N. 3. P. 281–291.
7. Placenta praevia and placenta accrete: diagnosis and management. Green Top Guideline. N. 27a. London: RCOG Press, 2018.
8. Rao K.P., Belogolovkin V., Yankowitz J. et al. Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa. Obstet. Gynecol. Surv. 2012. Vol. 67. P. 503–19.
9. Park H.-S., Cho H.-S. Management of massive hemorrhage in pregnant women with placenta previa. Anesth Pain Med (Seoul). 2020 Oct 30. Vol. 15. N. 4. P. 409–416. DOI: 10.17085/apm.20076. PMID: 33329843. PMCID: PMC7724116.
10. Kohn J.R., Shamshirsaz A.A., Popek E. et al. Pregnancy after endometrial ablation: a systematic review // BJOG. 2018. Vol. 125. N. 1. P. 43–53.
11. Jauniaux E., Gronbeck L., Bunce C. et al. Epidemiology of placenta previa accreta: a systematic review and meta-analysis // BMJ Open. 2019. Vol. 9. N. 11.
12. Castaneda S., Karrison T., Cibils L.A. Peripartum hysterectomy // J. Perinat. Med. 2000. Vol. 28. N. 6. P. 472–481.
13. Martimucci K. Bilinski R., Perez A.M. et al. Interpregnancy interval and abnormally invasive placentation // Acta Obstet. Gynecol. Scand. 2019. Vol. 98. N. 2. P. 183–187.
14. Radswiki T., Jones J. Placenta previa. Reference article, Radiopaedia.org. (accessed on 03 Aug 2022) https://doi.org/10.53347/rID-12477 DOI: https://doi.org/10.53347/rID-12477.
15. Mar W.A., Berggruen S., Atueyi U. et al. Ultrasound imaging of placenta accreta with MR correlation. Ultrasound Q. 2015. Vol. 31. N. 1. P. 23–33. DOI:10.1097/RUQ.0000000000000127.
16. Rahaim N.S., Whitby E.H. The MRI features of placental adhesion disorder and their diagnostic significance: systematic review. Clin Radiol. 2015. Vol. 70. N. 9. P. 917–925. DOI:10.1016/j.crad.2015.04.010.
17. Патологическое прикрепление (врастание плаценты). Проект КР РОАГ, 2022.
18. Jauniaux E., Ayres-de-Campos D., Langhoff-Roos J. et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders // Int. J. Gynaecol. Obstet. 2019. Vol. 146. N. 1. P. 20–24.
19. Chong Y., Zhang A., Wang Y. et al.. An ultrasonic scoring system to predict the prognosis of placenta accreta: a prospective cohort study. Medicine (Baltimore). 2018 Aug. Vol. 97. N. 35. DOI: 10.1097/MD.0000000000012111. PMID: 30170439. PMCID: PMC6392640.
20. Palacios-Jaraquemada J.M., D'Antonio F., Buca D. et al. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. J. Matern. Fetal. Neonatal Med. 2020. Vol. 33. N. 19. P. 3377–3384.
21. Expert Panel on Women’s Imaging et al. ACR appropriateness criteria® placenta accreta spectrum disorder. J. Am. Coll. Radiol. 2020. Vol. 17. N. 5S. P. S207–S214.
22. Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis // Am. J. Obstet. Gynecol. 2017. Vol. 217. N. 1. P. 27–36.
23. Hobson S.R., Kingdom J.C., Murji A. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders. J. Obstet. Gynaecol. Can. 2019. Vol. 41. N. 7. P. 1035–1049.
24. Society of Gynecologic Oncology et al. Placenta Accreta Spectrum // Am. J. Obstet. Gynecol. 2018. Vol. 219. N. 6. P. B2–B16.
25. Familiari A., Liberati M., Lim P. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 2018. Vol. 97. N. 5. P. 507–520.
26. Poder L., Weinstein S., Maturen K.E. et al. ACR appropriateness criteria® placenta accreta spectrum disorder. J. Am. Coll. Radiol. 2020. Vol. 17. N. 5. P. S207–S214
27. Jha P., Pōder L., Bourgioti C. et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur. Radiol. 2020. Vol. 30. N. 5. P. 2604–2615